Valsartan and Hydrochlorothiazide
Valsartan and Hydrochlorothiazide is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Valsartan and Hydrochlorothiazide; Generic name: VALSARTAN AND HYDROCHLOROTHIAZIDE; Drug class: Thiazide Diuretic [EPC].
| Brand name | Valsartan and Hydrochlorothiazide |
|---|---|
| Generic name | VALSARTAN AND HYDROCHLOROTHIAZIDE |
| Drug class | Thiazide Diuretic [EPC] |
| Manufacturer | Northwind Health Company, LLC |
| Used for | 1 INDICATIONS AND USAGE Valsartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including hydrochlorothiazide and the angiotensin II receptor blocker (ARB) class to which valsartan principally belongs. There are no controlled trials demonstrating risk reduction with valsartan and hydrochlorothiazide tablets. Control of high blood pressure should be part of comprehensive cardiovascul |
| Dosage | 2 DOSAGE AND ADMINISTRATION • Dose once daily. Titrate as needed to a maximum dose of 320/25mg ( 2 ) • May be used as add-on/switch therapy for patients not adequately controlled on any of the components (valsartan or HCTZ) ( 2 ) • May be substituted for titrated components ( 2.3 ) 2.1 General Considerations The usual starting dose is valsartan and hydrochlorothiazide tablets 160/12.5 mg once daily. The dosage can be increased after 1 to 2 weeks of therapy to a maximum of one 320/25 tablet once |
| Warnings | WARNING:FETAL TOXICITY • When pregnancy is detected, discontinue valsartan and hydrochlorothiazide tablets as soon as possible. (5.1 ) • Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. (5.1 ) WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue valsartan and hydrochlorothiazide tablets as soon as possible. (5.1) Drugs that act directly on the renin-angiotensin syste |
| Active ingredient(s) | HYDROCHLOROTHIAZIDE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=191d5710-7b8a-0b61-e063-6394a90afd41 |